Anastrozole placebo + Letrozole placebo + CAMIZESTRANT for neoplasm metastasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 30 Jun 2021: Trial started, NCT04964934
  2. 16 Jul 2021: Trial registered, NCT04964934

The trials

NCT04964934: Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)

State
Under way
Phase
Phase 3
People
315 taking part
Started
30 Jun 2021
Primary completion
30 Jun 2025
Arms
AZD9833 + palbociclib, abemaciclib or ribociclib
Results
None posted
  1. 30 Jun 2021: Trial started
  2. 16 Jul 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.